The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats.

Efavirenz, a potent nonnucleoside reverse transcriptase inhibitor widely prescribed for the treatment of HIV infection, produces renal tubular epithelial cell necrosis in rats but not in cynomolgus monkeys or humans. This species selectivity in nephrotoxicity could result from differences in the production or processing of reactive metabolites, or both. A detailed comparison of the metabolites produced by rats, monkeys, and humans revealed that rats produce a unique glutathione adduct. The mechanism of formation and role of this glutathione adduct in the renal toxicity were investigated using both chemical and biochemical probes. Efavirenz was labeled at the methine position on the cyclopropyl ring with the stable isotope deuterium, effectively reducing the formation of the cyclopropanol metabolite, an obligate precursor to the glutathione adduct. This substitution markedly reduced both the incidence and severity of nephrotoxicity as measured histologically. Further processing of this glutathione adduct was also important in producing the lesion and was demonstrated by inhibiting gamma-glutamyltranspeptidase with acivicin pretreatment (10 mg/kg, IV) prior to dosing with efavirenz. Again, both the incidence and severity of the nephrotoxicity were reduced, such that four of nine rats given acivicin were without detectable lesions. These studies provide compelling evidence that a species-specific formation of glutathione conjugate(s) from efavirenz is involved in producing nephrotoxicity in rats. Mechanisms are proposed for the formation of reactive metabolites that could be responsible for the renal toxicity observed in rats.

[1]  D. Liebler,et al.  S-(2-chloroacetyl)glutathione, a reactive glutathione thiol ester and a putative metabolite of 1,1-dichloroethylene. , 1988, Biochemistry.

[2]  W B Jakoby,et al.  Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. , 1974, The Journal of biological chemistry.

[3]  A. Y. Lu,et al.  Kinetic isotope effects in cytochrome P-450-catalyzed oxidation reactions. Intermolecular and intramolecular deuterium isotope effects during the N-demethylation of N,N-dimethylphentermine. , 1980, The Journal of biological chemistry.

[4]  James R. Moore,et al.  Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor , 1998 .

[5]  J. Maguire,et al.  5-ethyl-5-phenylhydantoin N-glucuronide, the major urinary metabolite of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog. , 1982, Drug Metabolism And Disposition.

[6]  N. Curthoys,et al.  Characterization and physiological function of rat renal gamma-glutamyltranspeptidase. , 1979, Enzyme.

[7]  Douglas Richman,et al.  Viral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies , 1996, Annals of Internal Medicine.

[8]  K. Mohri,et al.  Bucolome N-glucuronide: purification and identification of a major metabolite of bucolome in rat bile. , 1985, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  M. W. Anders,et al.  Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. , 1986, Biochemical pharmacology.

[10]  W. Dekant,et al.  Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. , 1987, Biochemical pharmacology.

[11]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[12]  C. Witmer,et al.  Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat. , 1992, Toxicology and applied pharmacology.

[13]  T. Monks,et al.  Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[14]  A. Mutlib,et al.  Liquid chromatography/mass spectrometry and high-field nuclear magnetic resonance characterization of novel mixed diconjugates of the non-nucleoside human immunodeficiency virus-1 reverse transcriptase inhibitor, efavirenz. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[15]  L. Pohl,et al.  Determination of toxic pathways of metabolism by deuterium substitution. , 1984, Drug metabolism reviews.

[16]  B. Ketterer,et al.  Glutathione Conjugation: Mechanisms and Biological Significance , 1989 .

[17]  W. Dekant,et al.  Bioactivation of xenobiotics by formation of toxic glutathione conjugates. , 1991, Chemico-biological interactions.

[18]  M. P. Arlotto,et al.  Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. , 1987, Archives of biochemistry and biophysics.

[19]  T. Igarashi,et al.  SEX AND SPECIES DIFFERENCES IN GLUTATHIONE S-TRANSFERASE ACTIVITIES , 1989, Drug metabolism and drug interactions.

[20]  L. Lash,et al.  Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene. , 1985, The Journal of pharmacology and experimental therapeutics.

[21]  D. Birt,et al.  Direct enzymatic assay for reduced and oxidized glutathione. , 1984, Journal of pharmacological methods.

[22]  W. Dekant,et al.  Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. , 1988, Critical reviews in toxicology.

[23]  P. van Bladeren,et al.  The glutathione conjugates of tert-butyl hydroquinone as potent redox cycling agents and possible reactive agents underlying the toxicity of butylated hydroxyanisole. , 1992, Biochemical and biophysical research communications.

[24]  R. Nilsson,et al.  Immunohistochemical Localization of α and φ Class Glutathione Transferases in Normal Human Tissues , 1993 .

[25]  N. Vermeulen,et al.  Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. , 1995, Pharmacological reviews.

[26]  T. Baillie,et al.  Metabolism of N-methylformamide in mice: primary kinetic deuterium isotope effect and identification of S-(N-methylcarbamoyl)glutathione as a metabolite. , 1987, The Journal of pharmacology and experimental therapeutics.

[27]  W. Dekant,et al.  Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Ray Baker,et al.  Mechanism in organic chemistry , 1971 .

[29]  K. Snell,et al.  Biochemical toxicology : a practical approach , 1987 .

[30]  W. L. Nelson,et al.  Synthesis and identification of the N-glucuronides of norgallopamil and norverapamil, unusual metabolites of gallopamil and verapamil. , 1990, The Journal of pharmacology and experimental therapeutics.

[31]  J. Trudell,et al.  Intramolecular determination of primary kinetic isotope effects in hydroxylations catalyzed by cytochrome P-450. , 1977, Biochemical and biophysical research communications.

[32]  B. Ketterer.  Detoxication reactions of glutathione and glutathione transferases. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  N. Ballatori,et al.  Glutathione-degrading capacities of liver and kidney in different species. , 1990, Biochemical pharmacology.

[34]  W. Dekant,et al.  Glutathione-dependent biosynthesis and bioactivation of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine, the glutathione and cysteine S-conjugates of dichloroacetylene, in rat tissues and subcellular fractions. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[35]  A. J. Gandolfi,et al.  Deuterium isotope effect on the metabolism and toxicity of 1,2-dibromoethane. , 1983, Toxicology and applied pharmacology.

[36]  L. Pohl,et al.  Nephrotoxicity of chloroform: metabolism to phosgene by the mouse kidney. , 1984, Toxicology and applied pharmacology.

[37]  R. Waring,et al.  The acetylation of S-alkylcysteines by the rat. , 1969, Biochemical pharmacology.

[38]  W. Dekant,et al.  Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. , 1988, Chemical research in toxicology.

[39]  A. Mutlib,et al.  Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[40]  B. Mannervik,et al.  Glutathione transferases--structure and catalytic activity. , 1988, CRC critical reviews in biochemistry.

[41]  P. van Bladeren,et al.  Active site-directed irreversible inhibition of glutathione S-transferases by the glutathione conjugate of tetrachloro-1,4-benzoquinone. , 1988, The Journal of biological chemistry.

[42]  N. Curthoys,et al.  The interorgan metabolism of glutathione. , 1980, The International journal of biochemistry.

[43]  A. J. Gandolfi,et al.  The formation and biotransformation of cysteine conjugates of halogenated ethylenes by rabbit renal tubules. , 1984, Chemico-biological interactions.

[44]  A. Elfarra,et al.  Reactivity of cysteine S-conjugate sulfoxides: formation of S-[1-chloro-2-(S-glutathionyl)vinyl]-L-cysteine sulfoxide by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with glutathione. , 1991, Chemical research in toxicology.

[45]  H. Jörnvall,et al.  Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  E. Lock,et al.  The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. , 1984, Toxicology and applied pharmacology.